Produce a smallpox drug in anticipation of bioterrorism

In anticipation of the use of the virus to launch a biological or terrorist attack, the Food and Drug Administration of the States United States approved the production of the drug "On the disease in 1980, after 3 years of surveillance of the last known case of him."
D. Anthony Fussy, director of the National Institute of Allergy and Infectious Diseases, said: "The approval of the production of the drug is good, since smallpox is a deadly disease that has caused more than 30 percent of those infected.
The New York Times reported that the world has eradicated smallpox for decades, but that its virus is still found in several lab or laboratory freezers in the world, one in Russia and the United States. other in Atlanta.
In anticipation of one of these samples in the hands of terrorist groups, allowing them to launch a biological warfare through grass revitalization [194] The US company Sega Technologies has obtained federal approval to develop a drug that fights the disease and recently has access to Tycoferat, the so-called TB.
Peter Hughes, Dean of the Faculty of Medicine "He did not test the drug directly on humans, but tried successfully on primates and rabbits infected with monkeypox and rabbits."
He also cited his experience of 359 healthy volunteers who suffered minor side effects. "The efforts to vaccinate the grandfather have ended," he said After the declaration of the official elimination, all children after 1980 are immunized, which means that the virus can become an epidemic when it comes back . "
He adds:" may again spread the virus, resulting from an accidental accident or another intentional type of bioterrorism. "